Home > IT and Telecommunications > EMEA (Europe, Middle East and Africa) Competent Cells Market 2017 Forecast to 2022...

EMEA (Europe, Middle East and Africa) Competent Cells Market 2017 Forecast to 2022

No. of Pages: 118Published : 29 Nov 2017

Request Sample
 

This report studies the Competent Cells market. Competent cells are bacteria which can accept extra-chromosomal DNA or plasmids. Cells can be made competent in several ways. One such way is to "shock" it, which involves cooling the bacteria in a Calcium Chloride bath at 0 degrees Celsius, then quickly heating it to around 47 degrees Celsius for approximately 90 seconds (too long will denature the cell membrane, killing the bacteria). The calcium chloride ions neutralize the repulsion between the negatively charged phospholipid heads of the cell membrane and the negatively charged phosphate groups on the DNA. The quick heat shock creates a thermal gradient which, in turn, creates a draft leading into the cell, allowing extra-chromosomal DNA (such as plasmids) to enter the cell, allowing the bacterium to be genetically modifed. Scope of the Report: This report focuses on the Competent Cells in EMEA market, covering Europe, Middle East and Africa, This report categorizes the market based on manufacturers, regions, type and application. Market Segment by Manufacturers, this report covers Merck KGaA Thermo Fisher Scientific Agilent Technologies Takara Bio Promega Corporation Beijing TransGen Biotech GeneScript Corporation Yeastern Biotech New England Biolabs QIAGEN N.V. OriGene Technologies Lucigen Zymo Research Bio-Rad Laboratories Bioline Delphi Genetics IBA GmBH Cell Applications BioDynamics Laboratory Scarab Genomics GCC Biotech SMOBIO Technology Edge BioSystems Market Segment by Regions, regional analysis covers Europe (Germany, France, UK, Russia, Italy and Turkey) Middle East (Saudi Arabia, Israel, UAE and Iran) Africa (South Africa, Nigeria, Egypt and Algeria) Market Segment by Type, covers Chemically Competent Cells Electrocompetent Cells Market Segment by Applications, can be divided into Subcloning & Routine Cloning Phage Display Library Construction Toxic/Unstable DNA Cloning High-Throughput Cloning Protein Expression Mutagenesis Single-Stranded DNA Production Bacmid creation Cre-lox recombination (PIR1/PIR2) There are 13 Chapters to deeply display the EMEA Competent Cells market. Chapter 1, to describe Competent Cells Introduction, product scope, market overview, market opportunities, market risk, market driving force; Chapter 2, to analyze the top manufacturers of Competent Cells, with sales, revenue, and price of Competent Cells, in 2016 and 2017; Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017; Chapter 4, to show the EMEA market by regions, with sales, revenue and market share of Competent Cells, for each region, from 2012 to 2017; Chapter 5, 6, 7, to analyze the market by regions, manufacturers, type and application, with sales, revenue and market share by key countries in these regions; Chapter 8 and 9, to show the market by type and application, with sales market share and growth rate by type, application, from 2012 to 2017; Chapter 10, Competent Cells market forecast, by regions, type and application, with sales and revenue, from 2017 to 2022; Chapter 11, 12 and 13, to describe Competent Cells research findings and conclusion, sales channel, distributors, traders, dealers, appendix and data source

 

Table of Contents 1 Market Overview 1.1 Competent Cells Introduction 1.2 Market Analysis by Type 1.2.1 Chemically Competent Cells 1.2.2 Electrocompetent Cells 1.3 Market Analysis by Applications 1.3.1 Subcloning & Routine Cloning 1.3.2 Phage Display Library Construction 1.3.3 Toxic/Unstable DNA Cloning 1.3.4 High-Throughput Cloning 1.3.5 Protein Expression 1.3.6 Mutagenesis 1.3.1 Single-Stranded DNA Production 1.3.2 Bacmid creation 1.3.3 Cre-lox recombination (PIR1/PIR2) 1.4 Market Analysis by Regions 1.4.1 Europe (Germany, France, UK, Italy, Russia and Turkey) 1.4.1.1 Germany Market States and Outlook (2012-2022) 1.4.1.2 France Market States and Outlook (2012-2022) 1.4.1.3 UK Market States and Outlook (2012-2022) 1.4.1.4 Italy Market States and Outlook (2012-2022) 1.4.1.5 Russia Market States and Outlook (2012-2022) 1.4.1.6 Turkey Market States and Outlook (2012-2022) 1.4.2 Middle East (Saudi Arabia, Israel, UAE and Iran) 1.4.2.1 Saudi Arabia Market States and Outlook (2012-2022) 1.4.2.2 UAE Market States and Outlook (2012-2022) 1.4.2.3 Israel Market States and Outlook (2012-2022) 1.4.2.4 Iran Market States and Outlook (2012-2022) 1.4.3 Africa (South Africa, Nigeria, Egypt and Algeria) 1.4.3.1 South Africa Market States and Outlook (2012-2022) 1.4.3.2 Nigeria Market States and Outlook (2012-2022) 1.4.3.3 Egypt Market States and Outlook (2012-2022) 1.4.3.4 Algeria Market States and Outlook (2012-2022) 1.5 Market Dynamics 1.5.1 Market Opportunities 1.5.2 Market Risk 1.5.3 Market Driving Force 2 Manufacturers Profiles 2.1 Merck KGaA 2.1.1 Business Overview 2.1.2 Competent Cells Type and Applications 2.1.2.1 Type 1 2.1.2.2 Type 2 2.1.3 Merck KGaA Competent Cells Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.2 Thermo Fisher Scientific 2.2.1 Business Overview 2.2.2 Competent Cells Type and Applications 2.2.2.1 Type 1 2.2.2.2 Type 2 2.2.3 Thermo Fisher Scientific Competent Cells Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.3 Agilent Technologies 2.3.1 Business Overview 2.3.2 Competent Cells Type and Applications 2.3.2.1 Type 1 2.3.2.2 Type 2 2.3.3 Agilent Technologies Competent Cells Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.4 Takara Bio 2.4.1 Business Overview 2.4.2 Competent Cells Type and Applications 2.4.2.1 Type 1 2.4.2.2 Type 2 2.4.3 Takara Bio Competent Cells Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.5 Promega Corporation 2.5.1 Business Overview 2.5.2 Competent Cells Type and Applications 2.5.2.1 Type 1 2.5.2.2 Type 2 2.5.3 Promega Corporation Competent Cells Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.6 Beijing TransGen Biotech 2.6.1 Business Overview 2.6.2 Competent Cells Type and Applications 2.6.2.1 Type 1 2.6.2.2 Type 2 2.6.3 Beijing TransGen Biotech Competent Cells Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.7 GeneScript Corporation 2.7.1 Business Overview 2.7.2 Competent Cells Type and Applications 2.7.2.1 Type 1 2.7.2.2 Type 2 2.7.3 GeneScript Corporation Competent Cells Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.8 Yeastern Biotech 2.8.1 Business Overview 2.8.2 Competent Cells Type and Applications 2.8.2.1 Type 1 2.8.2.2 Type 2 2.8.3 Yeastern Biotech Competent Cells Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.9 New England Biolabs 2.9.1 Business Overview 2.9.2 Competent Cells Type and Applications 2.9.2.1 Type 1 2.9.2.2 Type 2 2.9.3 New England Biolabs Competent Cells Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.10 QIAGEN N.V. 2.10.1 Business Overview 2.10.2 Competent Cells Type and Applications 2.10.2.1 Type 1 2.10.2.2 Type 2 2.10.3 QIAGEN N.V. Competent Cells Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.11 OriGene Technologies 2.11.1 Business Overview 2.11.2 Competent Cells Type and Applications 2.11.2.1 Type 1 2.11.2.2 Type 2 2.11.3 OriGene Technologies Competent Cells Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.12 Lucigen 2.12.1 Business Overview 2.12.2 Competent Cells Type and Applications 2.12.2.1 Type 1 2.12.2.2 Type 2 2.12.3 Lucigen Competent Cells Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.13 Zymo Research 2.13.1 Business Overview 2.13.2 Competent Cells Type and Applications 2.13.2.1 Type 1 2.13.2.2 Type 2 2.13.3 Zymo Research Competent Cells Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.14 Bio-Rad Laboratories 2.14.1 Business Overview 2.14.2 Competent Cells Type and Applications 2.14.2.1 Type 1 2.14.2.2 Type 2 2.14.3 Bio-Rad Laboratories Competent Cells Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.15 Bioline 2.15.1 Business Overview 2.15.2 Competent Cells Type and Applications 2.15.2.1 Type 1 2.15.2.2 Type 2 2.15.3 Bioline Competent Cells Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.16 Delphi Genetics 2.16.1 Business Overview 2.16.2 Competent Cells Type and Applications 2.16.2.1 Type 1 2.16.2.2 Type 2 2.16.3 Delphi Genetics Competent Cells Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.17 IBA GmBH 2.17.1 Business Overview 2.17.2 Competent Cells Type and Applications 2.17.2.1 Type 1 2.17.2.2 Type 2 2.17.3 IBA GmBH Competent Cells Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.18 Cell Applications 2.18.1 Business Overview 2.18.2 Competent Cells Type and Applications 2.18.2.1 Type 1 2.18.2.2 Type 2 2.18.3 Cell Applications Competent Cells Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.19 BioDynamics Laboratory 2.19.1 Business Overview 2.19.2 Competent Cells Type and Applications 2.19.2.1 Type 1 2.19.2.2 Type 2 2.19.3 BioDynamics Laboratory Competent Cells Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.20 Scarab Genomics 2.20.1 Business Overview 2.20.2 Competent Cells Type and Applications 2.20.2.1 Type 1 2.20.2.2 Type 2 2.20.3 Scarab Genomics Competent Cells Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.21 GCC Biotech 2.21.1 Business Overview 2.2.2 Competent Cells Type and Applications 2.21.2.1 Type 1 2.21.2.2 Type 2 2.21.3 GCC Biotech Competent Cells Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.22 SMOBIO Technology 2.22.1 Business Overview 2.22.2 Competent Cells Type and Applications 2.22.2.1 Type 1 2.22.2.2 Type 2 2.22.3 SMOBIO Technology Competent Cells Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.23 Edge BioSystems 2.23.1 Business Overview 2.23.2 Competent Cells Type and Applications 2.23.2.1 Type 1 2.23.2.2 Type 2 2.23.3 Edge BioSystems Competent Cells Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 3 EMEA Competent Cells Market Competition, by Manufacturer 3.1 EMEA Competent Cells Sales and Market Share by Manufacturer 3.2 EMEA Competent Cells Revenue and Market Share by Manufacturer 3.3 EMEA Competent Cells Price by Manufacturer (2016-2017) 3.4 Market Concentration Rate 3.4.1 Top 3 Competent Cells Manufacturer Market Share 3.4.2 Top 5 Competent Cells Manufacturer Market Share 3.5 Market Competition Trend 4 EMEA Competent Cells Market Analysis by Regions 4.1 EMEA Competent Cells Sales, Revenue and Market Share by Regions 4.1.1 EMEA Competent Cells Sales by Regions (2012-2017) 4.1.2 EMEA Competent Cells Revenue by Regions (2012-2017) 4.2 Europe Competent Cells Sales and Growth (2012-2017) 4.3 Middle East Competent Cells Sales and Growth (2012-2017) 4.4 Africa Competent Cells Sales and Growth (2012-2017) 5 Europe Competent Cells by Countries, Type, Application and Manufacturers 5.1 Europe Competent Cells Sales, Revenue and Market Share by Countries 5.1.1 Europe Competent Cells Sales by Countries (2012-2017) 5.1.2 Europe Competent Cells Revenue by Countries (2012-2017) 5.1.3 Germany Competent Cells Sales and Growth (2012-2017) 5.1.4 France Competent Cells Sales and Growth (2012-2017) 5.1.5 UK Competent Cells Sales and Growth (2012-2017) 5.1.6 Russia Competent Cells Sales and Growth (2012-2017) 5.1.7 Italy Competent Cells Sales and Growth (2012-2017) 5.1.8 Turkey Competent Cells Sales and Growth (2012-2017) 5.2 Europe Competent Cells Sales and Revenue (value) by Manufacturers (2016-2017) 5.2.1 Europe Competent Cells Sales by Manufacturers (2016-2017) 5.2.2 Europe Competent Cells Revenue by Manufacturers (2016-2017) 5.3 Europe Competent Cells Sales by Type (2012-2017) 5.4 Europe Competent Cells Sales by Application (2012-2017) 6 Middle East Competent Cells by Countries, Type, Application and Manufacturers 6.1 Middle East Competent Cells Sales, Revenue and Market Share by Countries 6.1.1 Middle East Competent Cells Sales by Countries (2012-2017) 6.1.2 Middle East Competent Cells Revenue by Countries (2012-2017) 6.1.3 Saudi Arabia Competent Cells Sales and Growth (2012-2017) 6.1.4 Israel Competent Cells Sales and Growth (2012-2017) 6.1.5 UAE Competent Cells Sales and Growth (2012-2017) 6.1.6 Iran Competent Cells Sales and Growth (2012-2017) 6.2 Middle East Competent Cells Sales and Revenue (value) by Manufacturers (2016-2017) 6.2.1 Middle East Competent Cells Sales by Manufacturers (2016-2017) 6.2.2 Middle East Competent Cells Revenue by Manufacturers (2016-2017) 6.3 Middle East Competent Cells Sales by Type (2012-2017) 6.4 Middle East Competent Cells Sales by Application (2012-2017) 7 Africa Competent Cells by Countries, Type, Application and Manufacturers 7.1 Africa Competent Cells Sales, Revenue and Market Share by Countries 7.1.1 Africa Competent Cells Sales by Countries (2012-2017) 7.1.2 Africa Competent Cells Revenue by Countries (2012-2017) 7.1.3 South Africa Competent Cells Sales and Growth (2012-2017) 7.1.4 Nigeria Competent Cells Sales and Growth (2012-2017) 7.1.5 Egypt Competent Cells Sales and Growth (2012-2017) 7.1.6 Algeria Competent Cells Sales and Growth (2012-2017) 7.2 Middle East Competent Cells Sales and Revenue (value) by Manufacturers (2016-2017) 7.2.1 Middle East Competent Cells Sales by Manufacturers (2016-2017) 7.2.2 Middle East Competent Cells Revenue by Manufacturers (2016-2017) 7.3 Middle East Competent Cells Sales by Type (2012-2017) 7.4 Middle East Competent Cells Sales by Application (2012-2017) 8 EMEA Competent Cells Market Segment by Type 8.1 EMEA Competent Cells Sales, Revenue and Market Share by Type (2012-2017) 8.1.1 EMEA Competent Cells Sales and Market Share by Type (2012-2017) 8.1.2 EMEA Competent Cells Revenue and Market Share by Type (2012-2017) 8.2 Chemically Competent Cells Sales Growth and Price 10.2.1 EMEA Chemically Competent Cells Sales Growth (2012-2017) 10.2.2 EMEA Chemically Competent Cells Price (2012-2017) 8.3 Electrocompetent Cells Sales Growth and Price 10.3.1 EMEA Electrocompetent Cells Sales Growth (2012-2017) 10.3.2 EMEA Electrocompetent Cells Price (2012-2017) 9 EMEA Competent Cells Market Segment by Application 9.1 EMEA Competent Cells Sales Market Share by Application (2012-2017) 9.2 Subcloning & Routine Cloning Sales Growth (2012-2017) 9.3 Phage Display Library Construction Sales Growth (2012-2017) 9.4 Toxic/Unstable DNA Cloning Sales Growth (2012-2017) 9.5 High-Throughput Cloning Sales Growth (2012-2017) 9.6 Protein Expression Sales Growth (2012-2017) 9.7 Mutagenesis Sales Growth (2012-2017) 9.8 Single-Stranded DNA Production Sales Growth (2012-2017) 9.9 Bacmid creation Sales Growth (2012-2017) 9.10 Cre-lox recombination (PIR1/PIR2) Sales Growth (2012-2017) 10 EMEA Competent Cells Market Forecast (2017-2022) 10.1 EMEA Competent Cells Sales, Revenue and Growth Rate (2017-2022) 10.2 Competent Cells Market Forecast by Regions (2017-2022) 10.2.1 Europe Competent Cells Market Forecast by Regions (2017-2022) 10.2.1.1 Germany Competent Cells Sales Forecast 2017-2022 10.2.1.2 France Competent Cells Sales Forecast 2017-2022 10.2.1.3 UK Competent Cells Sales Forecast 2017-2022 10.2.1.4 Russia Competent Cells Sales Forecast 2017-2022 10.2.1.5 Italy Competent Cells Sales Forecast 2017-2022 10.2.1.6 Turkey Competent Cells Sales Forecast 2017-2022 10.2.2 Middle East Market Forecast by Regions (2017-2022) 10.2.2.1 Saudi Arabia Competent Cells Sales Forecast 2017-2022 10.2.2.2 Israel Competent Cells Sales Forecast 2017-2022 10.2.2.3 UAE Competent Cells Sales Forecast 2017-2022 10.2.2.4 Iran Competent Cells Sales Forecast 2017-2022 10.2.3 Africa Market Forecast by Regions (2017-2022) 10.2.3.1 South Africa Competent Cells Sales Forecast 2017-2022 10.2.3.2 Nigeria Competent Cells Sales Forecast 2017-2022 10.2.3.3 Egypt Competent Cells Sales Forecast 2017-2022 10.2.3.4 Algeria Competent Cells Sales Forecast 2017-2022 10.3 Competent Cells Market Forecast by Type (2017-2022) 10.4 Competent Cells Market Forecast by Application (2017-2022) 11 Sales Channel, Distributors, Traders and Dealers 11.1 Sales Channel 11.1.1 Direct Marketing 11.1.2 Indirect Marketing 11.1.3 Marketing Channel Future Trend 11.2 Distributors, Traders and Dealers 12 Research Findings and Conclusion 13 Appendix 13.1 Methodology 13.2 Analyst Introduction 13.3 Data Source

List of Tables and Figures Figure Competent Cells Picture Table Product Specifications of Competent Cells Figure EMEA Sales Market Share of Competent Cells by Types in 2016 Table Competent Cells Types for Major Manufacturers Figure Chemically Competent Cells Picture Figure Electrocompetent Cells Picture Table Competent Cells Sales Market Share by Applications in 2016 Figure Subcloning & Routine Cloning Picture Figure Phage Display Library Construction Picture Figure Toxic/Unstable DNA Cloning Picture Figure High-Throughput Cloning Picture Figure Protein Expression Picture Figure Mutagenesis Picture Figure Single-Stranded DNA Production Picture Figure Bacmid creation Picture Figure Cre-lox recombination (PIR1/PIR2) Picture Figure Germany Competent Cells Revenue (Value) and Growth Rate (2012-2022) Figure France Competent Cells Revenue (Value) and Growth Rate (2012-2022) Figure UK Competent Cells Revenue (Value) and Growth Rate (2012-2022) Figure Italy Competent Cells Revenue (Value) and Growth Rate (2012-2022) Figure Russia Competent Cells Revenue (Value) and Growth Rate (2012-2022) Figure Turkey Competent Cells Revenue (Value) and Growth Rate (2012-2022) Figure Saudi Arabia Competent Cells Revenue (Value) and Growth Rate (2012-2022) Figure UAE Competent Cells Revenue (Value) and Growth Rate (2012-2022) Figure Israel Competent Cells Revenue (Value) and Growth Rate (2012-2022) Figure Iran Competent Cells Revenue (Value) and Growth Rate (2012-2022) Figure South Africa Competent Cells Revenue (Value) and Growth Rate (2012-2022) Figure Nigeria Competent Cells Revenue (Value) and Growth Rate (2012-2022) Figure Egypt Competent Cells Revenue (Value) and Growth Rate (2012-2022) Figure Algeria Competent Cells Revenue (Value) and Growth Rate (2012-2022) Table Merck KGaA Basic Information, Manufacturing Base and Competitors Table Merck KGaA Competent Cells Type and Applications Table Merck KGaA Competent Cells Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors Table Thermo Fisher Scientific Competent Cells Type and Applications Table Thermo Fisher Scientific Competent Cells Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Agilent Technologies Basic Information, Manufacturing Base and Competitors Table Agilent Technologies Competent Cells Type and Applications Table Agilent Technologies Competent Cells Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Takara Bio Basic Information, Manufacturing Base and Competitors Table Takara Bio Competent Cells Type and Applications Table Takara Bio Competent Cells Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Promega Corporation Basic Information, Manufacturing Base and Competitors Table Promega Corporation Competent Cells Type and Applications Table Promega Corporation Competent Cells Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Beijing TransGen Biotech Basic Information, Manufacturing Base and Competitors Table Beijing TransGen Biotech Competent Cells Type and Applications Table Beijing TransGen Biotech Competent Cells Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table GeneScript Corporation Basic Information, Manufacturing Base and Competitors Table GeneScript Corporation Competent Cells Type and Applications Table GeneScript Corporation Competent Cells Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Yeastern Biotech Basic Information, Manufacturing Base and Competitors Table Yeastern Biotech Competent Cells Type and Applications Table Yeastern Biotech Competent Cells Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table New England Biolabs Basic Information, Manufacturing Base and Competitors Table New England Biolabs Competent Cells Type and Applications Table New England Biolabs Competent Cells Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table QIAGEN N.V. Basic Information, Manufacturing Base and Competitors Table QIAGEN N.V. Competent Cells Type and Applications Table QIAGEN N.V. Competent Cells Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table OriGene Technologies Basic Information, Manufacturing Base and Competitors Table OriGene Technologies Competent Cells Type and Applications Table OriGene Technologies Competent Cells Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Lucigen Basic Information, Manufacturing Base and Competitors Table Lucigen Competent Cells Type and Applications Table Lucigen Competent Cells Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Zymo Research Basic Information, Manufacturing Base and Competitors Table Zymo Research Competent Cells Type and Applications Table Zymo Research Competent Cells Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Bio-Rad Laboratories Basic Information, Manufacturing Base and Competitors Table Bio-Rad Laboratories Competent Cells Type and Applications Table Bio-Rad Laboratories Competent Cells Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Bioline Basic Information, Manufacturing Base and Competitors Table Bioline Competent Cells Type and Applications Table Bioline Competent Cells Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Delphi Genetics Basic Information, Manufacturing Base and Competitors Table Delphi Genetics Competent Cells Type and Applications Table Delphi Genetics Competent Cells Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table IBA GmBH Basic Information, Manufacturing Base and Competitors Table IBA GmBH Competent Cells Type and Applications Table IBA GmBH Competent Cells Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Cell Applications Basic Information, Manufacturing Base and Competitors Table Cell Applications Competent Cells Type and Applications Table Cell Applications Competent Cells Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table BioDynamics Laboratory Basic Information, Manufacturing Base and Competitors Table BioDynamics Laboratory Competent Cells Type and Applications Table BioDynamics Laboratory Competent Cells Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Scarab Genomics Basic Information, Manufacturing Base and Competitors Table Scarab Genomics Competent Cells Type and Applications Table Scarab Genomics Competent Cells Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table GCC Biotech Basic Information, Manufacturing Base and Competitors Table GCC Biotech Competent Cells Type and Applications Table GCC Biotech Competent Cells Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table SMOBIO Technology Basic Information, Manufacturing Base and Competitors Table SMOBIO Technology Competent Cells Type and Applications Table SMOBIO Technology Competent Cells Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Edge BioSystems Basic Information, Manufacturing Base and Competitors Table Edge BioSystems Competent Cells Type and Applications Table Edge BioSystems Competent Cells Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table EMEA Competent Cells Sales by Manufacturer (2016-2017) Figure EMEA Competent Cells Sales Market Share by Manufacturer in 2016 Figure EMEA Competent Cells Sales Market Share by Manufacturer in 2017 Table EMEA Competent Cells Revenue by Manufacturer (2016-2017) Figure EMEA Competent Cells Revenue Market Share by Manufacturer in 2016 Figure EMEA Competent Cells Revenue Market Share by Manufacturer in 2017 Table EMEA Competent Cells Price by Manufacturer (2016-2017) Figure EMEA Competent Cells Sales and Growth (2012-2017) Figure EMEA Competent Cells Revenue and Growth (2012-2017) Table EMEA Competent Cells Sales by Regions (2012-2017) Table EMEA Competent Cells Sales Market Share by Regions (2012-2017) Figure EMEA Competent Cells Sales Market Share by Regions in 2012 Figure EMEA Competent Cells Sales Market Share by Regions in 2016 Table EMEA Competent Cells Revenue by Regions (2012-2017) Table EMEA Competent Cells Revenue Market Share by Regions (2012-2017) Figure EMEA Competent Cells Revenue Market Share by Regions in 2012 Figure EMEA Competent Cells Revenue Market Share by Regions in 2016 Figure Europe Competent Cells Sales and Growth (2012-2017) Figure Middle East Competent Cells Sales and Growth (2012-2017) Figure Africa Competent Cells Sales and Growth (2012-2017) Figure Europe Competent Cells Revenue and Growth (2012-2017) Table Europe Competent Cells Sales by Countries (2012-2017) Table Europe Competent Cells Sales Market Share by Countries (2012-2017) Figure Europe Competent Cells Sales Market Share by Countries in 2012 Figure Europe Competent Cells Sales Market Share by Countries in 2016 Table Europe Competent Cells Revenue by Countries (2012-2017) Table Europe Competent Cells Revenue Market Share by Countries (2012-2017) Figure Europe Competent Cells Revenue Market Share by Countries in 2012 Figure Europe Competent Cells Revenue Market Share by Countries in 2016 Figure Germany Competent Cells Sales and Growth (2012-2017) Figure France Competent Cells Sales and Growth (2012-2017) Figure UK Competent Cells Sales and Growth (2012-2017) Figure Russia Competent Cells Sales and Growth (2012-2017) Figure Italy Competent Cells Sales and Growth (2012-2017) Figure Turkey Competent Cells Sales and Growth (2012-2017) Table Europe Competent Cells Sales by Manufacturer (2016-2017) Figure Europe Competent Cells Sales Market Share by Manufacturer in 2016 Figure Europe Competent Cells Sales Market Share by Manufacturer in 2017 Table Europe Competent Cells Revenue by Manufacturer (2016-2017) Figure Europe Competent Cells Revenue Market Share by Manufacturer in 2016 Figure Europe Competent Cells Revenue Market Share by Manufacturer in 2017 Table Europe Competent Cells Sales by Type (2012-2017) Table Europe Competent Cells Sales Share by Type (2012-2017) Table Europe Competent Cells Sales by Application (2012-2017) Table Europe Competent Cells Sales Share by Application (2012-2017) Figure Middle East Competent Cells Revenue and Growth (2012-2017) Table Middle East Competent Cells Sales by Countries (2012-2017) Table Middle East Competent Cells Sales Market Share by Countries (2012-2017) Figure Middle East Competent Cells Sales Market Share by Countries in 2012 Figure Middle East Competent Cells Sales Market Share by Countries in 2016 Table Middle East Competent Cells Revenue by Countries (2012-2017) Table Middle East Competent Cells Revenue Market Share by Countries (2012-2017) Figure Middle East Competent Cells Revenue Market Share by Countries in 2012 Figure Middle East Competent Cells Revenue Market Share by Countries in 2016 Figure Saudi Arabia Competent Cells Sales and Growth (2012-2017) Figure Israel Competent Cells Sales and Growth (2012-2017) Figure UAE Competent Cells Sales and Growth (2012-2017) Figure Iran Competent Cells Sales and Growth (2012-2017) Table Middle East Competent Cells Sales by Manufacturer (2016-2017) Figure Middle East Competent Cells Sales Market Share by Manufacturer in 2016 Figure Middle East Competent Cells Sales Market Share by Manufacturer in 2017 Table Middle East Competent Cells Revenue by Manufacturer (2016-2017) Figure Middle East Competent Cells Revenue Market Share by Manufacturer in 2016 Figure Middle East Competent Cells Revenue Market Share by Manufacturer in 2017 Table Middle East Competent Cells Sales by Type (2012-2017) Table Middle East Competent Cells Sales Share by Type (2012-2017) Table Middle East Competent Cells Sales by Application (2012-2017) Table Middle East Competent Cells Sales Share by Application (2012-2017) Figure Africa Competent Cells Revenue and Growth (2012-2017) Table Africa Competent Cells Sales by Countries (2012-2017) Table Africa Competent Cells Sales Market Share by Countries (2012-2017) Figure Africa Competent Cells Sales Market Share by Countries in 2012 Figure Africa Competent Cells Sales Market Share by Countries in 2016 Table Africa Competent Cells Revenue by Countries (2012-2017) Table Africa Competent Cells Revenue Market Share by Countries (2012-2017) Figure Africa Competent Cells Revenue Market Share by Countries in 2012 Figure Africa Competent Cells Revenue Market Share by Countries in 2016 Figure South Africa Competent Cells Sales and Growth (2012-2017) Figure Nigeria Competent Cells Sales and Growth (2012-2017) Figure Egypt Competent Cells Sales and Growth (2012-2017) Figure Algeria Competent Cells Sales and Growth (2012-2017) Table Middle East Competent Cells Sales by Manufacturer (2016-2017) Figure Middle East Competent Cells Sales Market Share by Manufacturer in 2016 Figure Middle East Competent Cells Sales Market Share by Manufacturer in 2017 Table Middle East Competent Cells Revenue by Manufacturer (2016-2017) Figure Middle East Competent Cells Revenue Market Share by Manufacturer in 2016 Figure Middle East Competent Cells Revenue Market Share by Manufacturer in 2017 Table Middle East Competent Cells Sales by Type (2012-2017) Table Middle East Competent Cells Sales Share by Type (2012-2017) Table Middle East Competent Cells Sales by Application (2012-2017) Table Middle East Competent Cells Sales Share by Application (2012-2017) Table EMEA Competent Cells Sales by Type (2012-2017) Table EMEA Competent Cells Sales Share by Type (2012-2017) Table EMEA Competent Cells Revenue by Type (2012-2017) Table EMEA Competent Cells Revenue Share by Type (2012-2017) Figure EMEA Chemically Competent Cells Sales Growth (2012-2017) Figure EMEA Chemically Competent Cells Price (2012-2017) Figure EMEA Electrocompetent Cells Sales Growth (2012-2017) Figure EMEA Electrocompetent Cells Price (2012-2017) Table EMEA Competent Cells Sales by Application (2012-2017) Table EMEA Competent Cells Sales Share by Application (2012-2017) Figure EMEA Subcloning & Routine Cloning Sales Growth (2012-2017) Figure EMEA Phage Display Library Construction Sales Growth (2012-2017) Figure EMEA Toxic/Unstable DNA Cloning Sales Growth (2012-2017) Figure EMEA High-Throughput Cloning Sales Growth (2012-2017) Figure EMEA Protein Expression Sales Growth (2012-2017) Figure EMEA Mutagenesis Sales Growth (2012-2017) Figure EMEA Single-Stranded DNA Production Sales Growth (2012-2017) Figure EMEA Bacmid creation Sales Growth (2012-2017) Figure EMEA Cre-lox recombination (PIR1/PIR2) Sales Growth (2012-2017) Figure EMEA Competent Cells Sales, Revenue and Growth Rate (2017-2022) Table EMEA Competent Cells Sales Forecast by Regions (2017-2022) Table EMEA Competent Cells Market Share Forecast by Regions (2017-2022) Table Europe Competent Cells Sales Forecast by Regions (2017-2022) Figure Germany Competent Cells Sales Forecast 2017-2022 Figure France Competent Cells Sales Forecast 2017-2022 Figure UK Competent Cells Sales Forecast 2017-2022 Figure Russia Competent Cells Sales Forecast 2017-2022 Figure Italy Competent Cells Sales Forecast 2017-2022 Figure Turkey Competent Cells Sales Forecast 2017-2022 Table Middle East Sales Forecast by Regions (2017-2022) Figure Saudi Arabia Competent Cells Sales Forecast 2017-2022 Figure Israel Competent Cells Sales Forecast 2017-2022 Figure UAE Competent Cells Sales Forecast 2017-2022 Figure Iran Competent Cells Sales Forecast 2017-2022 Table Africa Sales Forecast by Regions (2017-2022) Figure South Africa Competent Cells Sales Forecast 2017-2022 Figure Nigeria Competent Cells Sales Forecast 2017-2022 Figure Egypt Competent Cells Sales Forecast 2017-2022 Figure Algeria Competent Cells Sales Forecast 2017-2022 Table EMEA Competent Cells Sales Forecast by Type (2017-2022) Table EMEA Competent Cells Market Share Forecast by Type (2017-2022) Table EMEA Competent Cells Sales Forecast by Application (2017-2022) Table EMEA Competent Cells Market Share Forecast by Application (2017-2022) Table Distributors/Traders/ Dealers List Figure Europe Single-Stranded DNA Production Sales Growth (2012-2017) Figure Europe Bacmid creation Sales Growth (2012-2017) Figure Europe Cre-lox recombination (PIR1/PIR2) Sales Growth (2012-2017) Figure Europe Single-Stranded DNA Production Sales Growth (2012-2017) Figure Europe Bacmid creation Sales Growth (2012-2017) Figure Europe Cre-lox recombination (PIR1/PIR2) Sales Growth (2012-2017)

Qualitative Analysis covers:

  • Industry Status and Trends
  • Manufacturer/Company profiles, manufacturing base distribution, sales areas, product introduction, main business, market position and their competitors.
  • Product Development, Technology, Price, Cost, Manufacturing Process and Trends
  • Market segment by regions, types, applications and forecast
  • Market opportunities, potential, government policies and influence factors.
     

Quantitative Analysis covers:

  • Market size (value, sales/output, historical data and forecasts)
  • Sales/output/capacity, revenue, price, gross margin, market share, for top players. Through interviewing each manufacturers,  distributors, traders, dealers and buyers etc.
  • Cost structure, proportion, price trend, gross margin and trend, status and trend, for 10 years
  • Market size by types, regions, applications for 10 years
  • Market forecast based on the potential demand from downstream clients/buyers, government, influence factors and the total economic indication, maybe occur in following years.
     

Data Sources:

Methodology

 

Report ID : MSF486725

Publisher Name : GlobalInfoResearch

Why Market Size Forecasters?

  • Reports at Lowest Prices - Guaranteed
  • Fastest Growing Research Reports’ Database
  • Easy Customization Options
  • 24 X 7 Support Commitment
  • Certified, Safe & Secured Payments

Have A Question?

Ask UsView FAQ's